KYOTO, Japan, Nov. 27, 2023 /PRNewswire/ -- In a study recently published in the journal Scientific Reports, researchers from Shizuoka University, Noster Inc, and other groups in Japan identify gut-bacteria derived metabolites that can mitigate fatty liver disease. Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition that affects a sizable population of the developed world. Causes of NAFLD are stress, genetic predispositions, and preexisting conditions such as obesity. NAFLD is